** Shares of medical device maker Edwards Lifesciences EW.N rise 4.3% to $73.50 premarket
** Company late on Wednesday raised its 2025 sales forecast to a range of $5.7 billion to $6.1 billion, from between $5.6 billion and $6 billion earlier
** Edwards expects a tariff impact of 5 cents per share for 2025, with a larger hit expected in 2026
** Company posted Q1 adj. profit of 64 cents per share, beating analysts' estimates of 60 cents per share, according to data compiled by LSEG
** Co also reaffirmed its 2025 adjusted profit of $2.40 to $2.50 per share
** As of last close, EW has fallen 4.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.